Correlation Between Hear Atlast and GlucoTrack
Can any of the company-specific risk be diversified away by investing in both Hear Atlast and GlucoTrack at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hear Atlast and GlucoTrack into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hear Atlast Holdings and GlucoTrack, you can compare the effects of market volatilities on Hear Atlast and GlucoTrack and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hear Atlast with a short position of GlucoTrack. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hear Atlast and GlucoTrack.
Diversification Opportunities for Hear Atlast and GlucoTrack
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Hear and GlucoTrack is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Hear Atlast Holdings and GlucoTrack in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlucoTrack and Hear Atlast is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hear Atlast Holdings are associated (or correlated) with GlucoTrack. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlucoTrack has no effect on the direction of Hear Atlast i.e., Hear Atlast and GlucoTrack go up and down completely randomly.
Pair Corralation between Hear Atlast and GlucoTrack
Given the investment horizon of 90 days Hear Atlast Holdings is expected to generate 1.12 times more return on investment than GlucoTrack. However, Hear Atlast is 1.12 times more volatile than GlucoTrack. It trades about 0.07 of its potential returns per unit of risk. GlucoTrack is currently generating about -0.24 per unit of risk. If you would invest 0.05 in Hear Atlast Holdings on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Hear Atlast Holdings or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 97.67% |
Values | Daily Returns |
Hear Atlast Holdings vs. GlucoTrack
Performance |
Timeline |
Hear Atlast Holdings |
GlucoTrack |
Hear Atlast and GlucoTrack Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hear Atlast and GlucoTrack
The main advantage of trading using opposite Hear Atlast and GlucoTrack positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hear Atlast position performs unexpectedly, GlucoTrack can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlucoTrack will offset losses from the drop in GlucoTrack's long position.Hear Atlast vs. Wearable Health Solutions | Hear Atlast vs. BioLife Sciences | Hear Atlast vs. Innerscope Advertising Agency | Hear Atlast vs. GlucoTrack |
GlucoTrack vs. Nexgel Inc | GlucoTrack vs. Avinger | GlucoTrack vs. Sharps Technology | GlucoTrack vs. Innovative Eyewear |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |